A History of AlloDerm
AlloDerm was developed in 1994 by the biotechnology company LifeCell. Since AlloDerm was first made available for sale, the company’s growth rate and profits have skyrocketed. In fact, LifeCell experienced a 55% overall revenue growth between 2003 and 2004, and the trend has continued in more recent years, despite the company’s voluntary recalls of their product due to controversy surrounding their tissue collection methods.
AlloDerm is a skin graft generated from human skin that is collected from more than 50 tissue banks in the country. LifeCell patented a process to remove all epidermal and dermal cells without destroying the essential nature of the skin. This is supposed to reduce the risk of tissue rejection by the recipient’s immune system, but hernia repairs with AlloDerm have a comparatively high failure rate.
If you or someone you know received an AlloDerm hernia patch and is now experiencing adverse side effects, you may be eligible for compensation. Contact the hernia patch lawsuit attorneys at Williams Kherkher today at 800-761-3187 and learn more about your legal options.
AlloDerm’s Many Applications
The majority of complications with AlloDerm are related to hernia repairs, but incidents of AlloDerm failure have been reported in other kinds of operations as well. In effect, one of the biggest dangers of AlloDerm is its versatility. Some other uses of AlloDerm include:
- Breast reconstruction surgery after a mastectomy
- Rhinoplasty
- Septal perforation repair
- Burns
- Scars
- Gum and mouth surgeries
AlloDerm failure in any of the above can result in serious infections, abscesses, and additional surgeries.
Contact Us
If you or a loved one has been affected by medical complications involving AlloDerm, call the experienced AlloDerm lawsuit attorneys of Williams Kherkher at 800-761-3187 to discuss your rights today.
